PMS19 COST MINIMIZATION AND BUDGET IMPACT ANALYSIS OF RITUXIMAB VERSUS INFLIXIMAB, ADALIMUMAB, ETANERCEPT AND ABATACEPT IN RHEUMATOID ARTHRITIS FROM A PAYER PERSPECTIVE IN BRAZIL

✍ Scribed by MG Saggia; EA Santos; V Nasciben

• Book ID: 118609515
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 73 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)70821-4